NewsRamp is a PR & Newswire Technology platform that enhances press release distribution by adapting content to align with how and where audiences consume information. Recognizing that most internet activity occurs outside of search, NewsRamp improves content discovery by programmatically curating press releases into multiple unique formats—news articles, blog posts, persona-based TLDRs, videos, audio, and Zero-Click content—and distributing this content through a network of news sites, blogs, forums, podcasts, video platforms, newsletters, and social media.
FAQ: Quantumzyme's Attendance at the 2026 BIO International Convention
TL;DR
Quantumzyme Corp. gains networking opportunities at BIO International Convention to potentially secure collaborations and advance its enzyme-based pharmaceutical manufacturing solutions.
Quantumzyme Corp. will attend the 2026 BIO International Convention in San Diego for informal networking and observation to evaluate industry developments relevant to its technology.
Quantumzyme's attendance at the BIO Convention supports its mission to develop sustainable enzyme-based solutions that reduce waste and improve pharmaceutical manufacturing's environmental impact.
Quantumzyme Corp., a biotransformation company using quantum mechanics and AI, will network at the 2026 BIO Convention to explore enzyme-based pharmaceutical manufacturing innovations.
Found this article helpful?
Share it with your network and spread the knowledge!
Quantumzyme Corp. announced it plans to attend the 2026 BIO International Convention in San Diego, California, for informal networking and observation purposes only.
The convention will be held from June 22–25, 2026, in San Diego, California.
Quantumzyme aims to connect with industry peers, listen, learn, and engage in informal discussions to evaluate developments relevant to their technology and long-term objectives, while increasing industry awareness and maintaining dialogue with potential collaborators.
No, the company will not be presenting, exhibiting, sponsoring, or formally participating in conference programming; their attendance is limited to observation and networking activities only.
Naveen Kulkarni, Chief Executive Officer of Quantumzyme Corp., is quoted explaining the company's focus on listening, learning, and engaging in informal discussions at the convention.
Quantumzyme is a biotransformation company focused on advancing sustainable enzyme-based solutions for pharmaceutical manufacturing, using quantum mechanics, molecular modeling, AI-driven simulations, and computational enzyme engineering to develop efficient, waste-reducing biocatalysts.
The company states there can be no assurance that discussions initiated during the conference will result in any agreements, transactions, or future business relationships.
For more information and updates, visit www.quantumzymecorp.com and the company's profile at www.otcmarkets.com/stock/QTZM.
Additional information regarding the BIO International Convention is available at https://convention.bio.org.
Curated from NewMediaWire
